Company intelligence / Profile preview

INBRAIN Neuroelectronics

Barcelona, Catalonia, Spaininbrain-neuroelectronics.com ↗
Ownership
Private
Development stage
Clinical
01

Overview

INBRAIN has demonstrated the world’s first human use of a graphene-based BCI during brain tumor resection, showing high precision in distinguishing healthy from cancerous tissue. Ongoing clinical trials are evaluating safety and performance in neurological indications such as Parkinson's disease, epilepsy, stroke rehabilitation, and neurosurgical applications. The company’s BCI-Tx platform has shown superior signal fidelity versus traditional materials/devices in preclinical studies; early clinical results are promising but full efficacy data is pending.[3][6]

Therapeutic areas
OncologyNeurology
Modalities
DeviceBrain-computer interface (BCI)Bioelectronic therapyAI-powered platform technology
Industry
Implantable Medical Devices
02

Partnerships

Merck KGaA – joint development agreement to advance next-generation bioelectronic therapies powered by grapheneimec – collaboration on nanoelectronics integration for BCIsInstitut Català de Nanociència i Nanotecnologia (ICN2) – founding partner/research collaborationUniversity of Manchester/National University of Singapore – academic collaborations through key scientific advisors/foundersEuropean Commission Graphene Flagship project – major funding/supporterNorthern Care Alliance NHS Foundation Trust – clinical trial site partner in the UK.

Beyond the preview

Go deeper on INBRAIN Neuroelectronics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on INBRAIN Neuroelectronics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call